Skip to content

Florida · Nonprofit

The Familial Hypercholesterolemia Foundation

The Familial Hypercholesterolemia Foundation (Florida) receives grants from 18 organizations whose IRS filings report $1,594,548 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($721,550). 7 of them have funded it in more than one year, and 63% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.

Revenue FY2025
$11M
Funders on record
18
Grants received
$1.6M
Net assets
$7.2M
7/18 repeat funderspeak grant-dependency 11%
01What it does

What The Familial Hypercholesterolemia Foundation does

Mission

The mission of the Family Heart Foundation is to save generations of families from heart disease through timely identification and improved care of familial hypercholesterolemia (FH) and elevated lipoprotein(a) (Lp(a)). Through research, advocacy, and education we play a critical role in driving change and empower families to navigate their own health.

As stated on its FY2025 Form 990.

Programs

  1. EDUCATION: As an honest broker and neutral convener, the Family Heart Foundation provides education and tools to diverse audiences, from patients (through programs like Cholesterol Connect and our Community Engagement programs) to healthcare professionals, policymakers and payers (through programs like GOAL and Lp(a) AWARE). We host an annual scientific meeting, the Family Heart Global Summit and hold educational symposia at primary care medical conferences across the country.

    $2,846,957 spent
    38% of program spending
  2. RESEARCH: The Family Heart Foundation conducts independent, observational and implementation research. Our major research initiatives involve characterizing familial hypercholesterolemia through our national CASCADE FH Registry, analyzing current screening rates, diagnosis and burden of disease of high lipoprotein(a), FH, and high LDL-C through our Family Heart Database and quality improvement research through our FIND-Lp(a), GOAL and Lp(a) AW(a)RE programs. We have published over 70 peer-reviewed manuscripts most notably in the European Heart Journal entitled "Lipoprotein(a) and recurrent atherosclerotic cardiovascular events: the US Family Heart Database". This landmark publication was officially selected by the European Heart Journal as a Top 10 Dyslipidemia Study globally.

    $2,436,983 spent$10,000 earned by the program
    33% of program spending
  3. ADVOCACY: The Family Heart Foundation provides individualized resources to those living with genetic dyslipidemias through our Care Navigation Center. We also engage and support communities through on-site community engagement, education and screening programs. In addition, we raise awareness of these highly undiagnosed conditions through national media and awareness campaigns, The Family Heart Foundation established FHAwareness Day in 2012 and Lp(a) Awareness Day in 2021. We also work at a policy level (GOAL and Lp(a) AW(a)RE programs) to represent and elevate the voices of our community and improve care.

    $2,152,213 spent
    29% of program spending

The 3 programs described on its FY2025 Form 990, listed largest first by expense. Program spending in total: $7,436,153.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($5.7M) Expenses 100 ($5.0M) Net assets 100 ($7.5M)2018 Revenue 54 ($3.1M) Expenses 113 ($5.7M) Net assets 65 ($4.8M)2019 Revenue 61 ($3.5M) Expenses 100 ($5.0M) Net assets 45 ($3.4M)2020 Revenue 66 ($3.8M) Expenses 62 ($3.1M) Net assets 54 ($4.1M)2021 Revenue 84 ($4.8M) Expenses 57 ($2.9M) Net assets 81 ($6.0M)2022 Revenue 49 ($2.8M) Expenses 94 ($4.7M) Net assets 53 ($3.9M)2023 Revenue 115 ($6.5M) Expenses 126 ($6.4M) Net assets 56 ($4.2M)2024 Revenue 156 ($8.9M) Expenses 156 ($7.8M) Net assets 71 ($5.3M)2025 Revenue 188 ($11M) Expenses 176 ($8.9M) Net assets 96 ($7.2M)
'17'18'19'20'21'22'23'24'25
Revenue (188)Expenses (176)Net assets (96)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2017 to 2018, from $7.6M to $5.3M (−31%).

$7.6M
$5.3M
$3.6M
$4.4M
$6.4M
$4.5M
$5.3M
$7.4M
$8.7M
'17'18'19'20'21'22'23'24'25
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
2025
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2020 7% · 2021 9% · 2022 17% · 2023 3% · 2024 4%. Grants only. Government contracts and fees sit inside program revenue.

98% of The Familial Hypercholesterolemia Foundation’s revenue is contributions — more reliant on donations than three-quarters of its peers (7% for the typical peer).

This organization
Typical peer · 4,745 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 9 reported years ran a deficit.

$653k
’17
−$2.6M
’18
−$1.6M
’19
$635k
’20
$1.9M
’21
−$1.9M
’22
$173k
’23
$1.1M
’24
$1.8M
’25
9.9
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Chief executive

Katherine Wilemon

CEO/Board Member

Board chair

Seth Baum

Chair

As listed on its FY2025 Form 990.

'17'18'19'20'21'22'23'24'25
Listed111315131111141210
Joined·+4+2+1+0+2+5+2+1
No longer listed·20322243
03Who funds it

Who funds it, year by year

2017 → 2023: the base broadened from 2 funders to 4 funders, grant income rose $54k → $166k.

8 of 18 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 63% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of The Familial Hypercholesterolemia Foundation’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

The Familial Hypercholesterolemia Foundation leans on a few funders — its largest provides 45% of grant income and the top three 84%; half comes from just 2 funders.

the vertical line marks half of all grant income — 2 funders to its left

67% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund The Familial Hypercholesterolemia Foundation.

45%
largest funder
84%
top three
~3
effective funders

Largest funder’s share by year: 2017 82% · 2018 52% · 2019 60% · 2020 83% · 2021 69% · 2022 59% · 2023 77% — diversifying over time.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

29% of The Familial Hypercholesterolemia Foundation's funders are still giving 3 years after their first grant; 39% give in more than one year at all.

first grant+1y+2y+3y+4y+5y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

63% of The Familial Hypercholesterolemia Foundation's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $586k that is directly attributable, 100% of it comes from funders outside Florida, across 6 states.

IL
NY
MA
CA
NC
DC

In-state vs out-of-state, by year

’17
’19
’20
’21
’22
’23
Florida out of state home

Funder states come from each funder’s own filing. $1.0M arriving through sponsors registered in 7 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

The Familial Hypercholesterolemia Foundation runs a healthier operating margin than three-quarters of the 2,969 health nonprofits its size.

Operating margin17% · top quartile
Months of reserve9.9mo · top quartile
Revenue growth (annualized)8% · above the median

this organization peer median middle 50% of peers· 2,969 health nonprofits $10M–$100M, FY2025

Organizations like The Familial Hypercholesterolemia Foundation

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Florida

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

84% of spending goes to programs.

Program 84%Management 15%Fundraising 1%

Governance

5
board members
80%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990✓Audited financials

Public support

45%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 1 state

CA

Screen this organization

A dated, signed PDF of the compliance screen for The Familial Hypercholesterolemia Foundation: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds The Familial Hypercholesterolemia Foundation?
The Familial Hypercholesterolemia Foundation (Florida) receives grants from 18 organizations whose IRS filings report $1,594,548 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($721,550). 7 of them have funded it in more than one year, and 63% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
How many funders does The Familial Hypercholesterolemia Foundation have?
IRS filings report 18 organizations giving $1,594,548 in grants to The Familial Hypercholesterolemia Foundation, 7 of which have funded it in more than one year.
Who is the largest funder of The Familial Hypercholesterolemia Foundation?
FIDELITY INVESTMENTS CHARITABLE GIFT FUND is the largest funder on record, with $721,550 in grants. The full list of funders is on this page.
How can an organization like The Familial Hypercholesterolemia Foundation find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Florida. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

Play a game about who funds Familial Hypercholesterolemia →

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 18 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing